Big pharma deal: Bristol-Myers Squibb to buy Celgene
3:16
Big pharma deal: Bristol-Myers Squibb to buy Celgene
Jan 3, 2019
CNN
Celgene's Hugin: Drug Prices Should Be Fair
3:57
Celgene's Hugin: Drug Prices Should Be Fair
Jan 22, 2018
Bloomberg.comRebecca Spalding,Caroline Chen
What's Next for Celgene Corporation? | The Motley Fool
What's Next for Celgene Corporation? | The Motley Fool
Jan 12, 2016
fool.com
Amgen Inc. completed the acquisition of worldwide rights to Otezla from Celgene Corporation.
Amgen Inc. completed the acquisition of worldwide rights to Otezla from Celgene Corporation.
Nov 19, 2019
marketscreener.com
Summit-based Celgene Sold For $74 Billion
Summit-based Celgene Sold For $74 Billion
Jan 3, 2019
patch.com
SAGE Eldercare Receives Donation from Celgene Corporation
SAGE Eldercare Receives Donation from Celgene Corporation
Oct 20, 2017
patch.com
Celgene shares rise on plans to increase stock buybacks
Celgene shares rise on plans to increase stock buybacks
May 24, 2018
thestreet.com
Billions of Dollars on the Line for Celgene With These 3 Small Biotechs
Oct 19, 2019
nasdaq.com
Farmaceutska kompanija Celgene proslavila 10 godina rada u Evropi
Apr 15, 2016
avaz.ba
$
Whistleblower Claims Celgene Colluded With Charities to Drive Profits
Aug 1, 2016
FortuneSy Mukherjee
Rising through the ranks: Interview with Celgene CEO Mark Alles
Apr 5, 2016
thestreet.com
$
Celgene bet $1 billion that this biotech’s science can cure deadly cancers
Jun 30, 2015
FortuneLaura Lorenzetti
1:37
We See a Solid Pipeline for Undervalued Celgene
Nov 7, 2018
morningstar.com
3:47
FDA approves CAR-T cancer therapy
Jan 17, 2018
CBS News
$
U.S. Biotech Firm Celgene to Buy Impact Biomedicines for up to $7 Billion
Jan 8, 2018
FortuneReuters
BMS compra Celgene por US$ 74.000 millones y crea un gigante mundial de la industria biofarmacéutica
Jan 3, 2019
rpp.pe
Biogen, Celgene Close Higher on Earnings; Ford's Acquisitions Do Little to Move Stock -- ICYMI
Jan 26, 2018
thestreet.com
4:35
Celgene chief Alles discusses deal to acquire Impact Biomedicines, strategy for 2018
Jan 8, 2018
CNBC
Bristol-Myers Squibb buying Celgene in $74B deal
Jan 3, 2019
Fox BusinessMike Obel
6:00
Digging into Deals: Why Celgene Joined Up With Juno Therapeutics In 2015
Jan 18, 2016
YahooThe Motley Fool Videos
Principal Scientist, Translational Development – Celgene, New Jersey
Jun 16, 2017
vanderbilt.edu
4:03
Celgene CEO: There's nothing like pipeline success to reverse sentiment
Jun 4, 2018
CNBC
Celgene vend un médicament phare à Amgen pour fusionner avec BMS
Aug 26, 2019
lesechos.fr
3:50
Bristol-Myers, Celgene deal in focus
Jan 24, 2019
CNBC
3:02
Bristol-Myers intensifies efforts to salvage $91B Celgene deal
Mar 6, 2019
Fox BusinessJoe Williams
Celgene CEO: Impact Biomedicines deal will expand market for cancer treatments
Jan 8, 2018
Fox BusinessMatthew Wisner
Celgene Shareholders Excited by CAR-T News | The Motley Fool
Dec 19, 2017
fool.com
Should You Buy Celgene Stock? | The Motley Fool
Jun 15, 2018
fool.com
7:49
Celgene deal is a 'bold' move, says former Medtronic CEO
Jan 3, 2019
CNBC
Celgene Makes $9 Billion Cancer Treatment Play for Juno Therapeutics
Jan 22, 2018
thestreet.com
See more